SMi Groups' 4th annual BioBanking conference


Published on

SMi Groups' 4th annual BioBanking conference returns to London this June

Published in: Education, Business, Technology
1 Like
  • Be the first to comment

No Downloads
Total views
On SlideShare
From Embeds
Number of Embeds
Embeds 0
No embeds

No notes for slide

SMi Groups' 4th annual BioBanking conference

  1. 1. BOOK BYARY RU 28TH FEB 0 ‘Topics were interesting and informative’ Novartis SAVE £30 Y BOOK B H RC 31ST MA 0 SAVE £10 SMi presents their 4th annual... 23 - 24 Biobanking JUNE 2014 Holiday Inn Regents Park Hotel, London, UK NEW FOR 2014 KEY SPEAKERS • Key panel discussion on best strategies for use of samples with Novartis and Sanofi • Hear regulatory insight from EC and INSERM on data management • Explore how to further enhance sample quality to drive forward medical research • Evaluate the importance of networks to improve your organisation processes • Exclusive case study from AstraZeneca on the Biobank Application (ABBA) • Dr Mads Røpke, Senior Scientific Officer, LEO Pharma • Dr Anne Bahr, R&D Privacy Officer, Sanofi • Mr Steve Kelly, Team Leader, Discovery Sciences (Biobank), AstraZeneca • Paul Whittaker, Unit Head for Pre-clinical Biomarkers, Novartis • Arndt Schmitz, Senior Scientist, Global Biomarker Research, Bayer • Professor Berthold Huppertz, Director, CEO, Biobank Graz • Dr Kirstin Goldring, UCL Biobank and NIHR BioResource Senior Co-Ordinator, University College London • Mr Octavi Quintana-Trias, Director for the European Research Area, European Commission • Dr Giuseppina Bonizzi, Biobank and Biomolecular Resource Infrastructure Co-ordinator, European Institute of Oncology • Dr Javier Arias Díaz, Co-ordinator of the Council of Europe Bioethics Committee on Biobanks, Council of Europe PLUS TWO INTERACTIVE HALF-DAY POST-CONFERENCE WORKSHOPS 25th June 2014, Holiday Inn Regents Park Hotel, London, UK Ethics and Research in Biobanking Biobanking - start small and grow Hosted by Dr Ann Cooreman, COO, Tissue Solutions Hosted by Neil Benn, Managing Director, Ziath 8.30am - 12.15pm 1.00pm - 5.30pm BOOK BY 28TH FEBRUARY AND SAVE £300 / BOOK BY 31ST MARCH AND SAVE £100 Register online or fax your registration to +44 (0) 870 9090 712 or call +44 (0) 870 9090 711
  2. 2. Biobanking 2014 Day One | Monday 23rd June 2014 8.30 Registration & Coffee 1.40 9.00 Chairman's Opening Remarks Dr Brian Thomson, Director, Nottingham Health Science Biobank EXPLORING THE VALUE OF BIOSAMPLES 9.10 KEYNOTE ADDRESS Maximising the value of biosamples • Measuring the value of the biosample • Ensuring sustainability of sample collection • Adding value to the biosample: clinical and pathological annotation • Biosamples as part of the electronic health record Dr Brian Thomson, Director, Nottingham Health Science Biobank The importance, practicalities and challenges of Brain banking • CNS tissue banking in the UK • The importance of tissue banking in CNS research • Challenges associated with Brain Banking • Looking to the future Dr Claire Troakes, Brain Bank Co-ordinator, London Neurodegenerative Diseases Brain Bank, Institute of Psychiatry, King’s College London MAXIMISING THE POWER OF BIOBANKS 2.20 Further enabling sample quality for future research • Exploring technology as an advantage • Mitigating the risks of bad storage of samples • Emerging issues in sample quality strategically • Harmonization of sample quality in biobank networks Professor Berthold Huppertz, Director and CEO, Biobank Graz The AstraZeneca Biobank Application (ABBA) • Highly detailed level of sample tracking • Standardised sample characterisation data across clinical studies • Improved visibility of sample catalogue • Improved governance over samples Steve Kelly, Team Leader, Discovery Sciences (Biobank), AstraZeneca 3.00 Afternoon Tea 10.30 Morning Coffee 3.30 11.00 Case study: Establishing a repository for patient samples from clinical studies • Creating biobanking structures to enable future research on clinical patient samples • Implementing framework for combining molecular profiling of samples with patient metadata • Evaluating practical, legal and regulatory implications • An industry perspective Dr Mads Røpke, Senior Scientific Advisor, LEO Pharma Supporting Biobanks and BioResources at UCL • Diversity of biobanking requirements in academia • A biobanking model to support academics • Tissue access for patient benefit • A national approach to BioResources Dr Kirstin Goldring, UCL Biobank and NIHR BioResource Senior Co-Ordinator, University College London 9.50 11.40 Challenges in reusing samples: developing an effective consent form • Introduction to EU Personal Data Protection principles and their application to Human Biological Samples • Coding, withdrawl and re-using of personal data and biological samples • What should be included in the Informed Consent form? • Last updates regarding the new EU Data Protection regulation draft Dr Anne Bahr, R&D Privacy Officer, Sanofi 12.20 Networking Lunch 4.10 4.50 Moving from clinical sample to laboratory measurement: automating epidemiological research • Highlight the challenges associated with accessing and measuring clinical samples for large scale epidemiology research • Use of automation for efficiently accessing and preparing samples for measurement • Case studies for projects producing genetic and clinical biochemistry research measurements from thousands of samples • Methods for controlling measurement error and maximising research application Matt Sims, Head of Research Operations, MRC Epidemiology, University of Cambridge Chairman's Closing Remarks and Close of Day One Register online at: • Alternatively fax Who should attend? SPONSORSHIP AND EXHIBITION OPPORTUNITIES Heads of Department, Directors, Managers, Team Leaders of: • Biobanking • Biorepository • Biological Sample Management • Biosample Management • Pharmacogenomics • Pathology • Genomics • Personalised Medicine • • • • • • Translational Medicine Lab Management Inventory Management Molecular Technologies Biologics Research Data Privacy / Protection / Security Officers • Quality Control and Quality Management • • • • • • • • Research and Development Supply Chain Population based biobanks Disease based biobanks Hospital Trusts Research Institutes Tecnology Transfer Bioinnovation SMi offer sponsorship, exhibition, advertising and branding packages, uniquely tailored to complement your company’s marketing strategy. Prime networking opportunities exist to entertain, enhance and expand your client base within the context of an independent discussion specific to your industry. Should you wish to join the increasing number of companies benefiting from sponsoring our conferences please call: Alia Malick on +44 (0) 20 7827 6168 or email:
  3. 3. 8.30 • Audiovisual materials have been prepared to inform patients and to facilitate the work of our research nurse • IBBRI is integrated with the Department of Pathology • A highly integrated software system allows to manage all aspects of biobanked samples Dr Giuseppina Bonizzi, Biobank and Biomolecular Resource Infrastructure (IBBRI) Co-ordinator, European Institute of Oncology, Milan, Italy Registration & Coffee 9.00 Day Two | Tuesday 24th June 2014 Chairman's Opening Remarks Dr Brian Thomson, Director, Nottingham Health Science Biobank SPOTLIGHT ON REGULATION AND ETHICS 9.10 9.50 10.30 KEYNOTE ADDRESS Impact of the new Data Protection regulation on biobanking • Assessing the forthcoming regulation in the context of biobanks • Participants protection in research biobanking, new rights from the Data Protection regulation • Impact of the forthcoming regulation on research biobanking in the light of European infrastructures • Impact of the forthcoming regulation on the industry and academia partnerships Dr Emmanuelle Rial-Sebbag, Permanent Research Fellow, Institut Ethics in biobanking – a CoE perspective • Ethical principles at stake • The dilemma of informed consent • The importance of a good policy • Building trust Dr Javier Arias Díaz, Co-ordinator of the Council of Europe Bioethics Committee on Biobanks, Council of Europe Morning Coffee 2.20 Biobanking to support large-scale research • Large-scale research often involves the collection and storage of tens of thousands of human samples from around the world and samples may be stored for decades prior to use. This can create a unique set of challenges to provide suitable sample collection, processing, transport and storage • Assay requirements may differ between projects; from simple biomarker investigations up to ‘Omic’ studies and involve a few thousand samples up to several hundred thousand. Biobanking solutions need to be flexible to meet changing demands in biomarker analysis • The experience of CTSU and UK Biobank - sample stability studies are paramount to support the utility of large-scale biobanks Dr Mike Hill, Laboratory Director, CTSU Wolfson Laboratories, Nuffield Department of Population Health, University of Oxford 3.00 Afternoon Tea 3.20 Research biobanking in a pharmaceutical industry setting • Rationale for biobanking in biomarker research and validation • Experiences with the IMI: collaborations • Discussion of European oncology case studies Arndt Schmitz, Senior Scientist, Global Biomarker Research, Bayer 4.00 Panel discussion: strategies for sample usage • Challenges of using samples commercially • Evaluating the validity of using samples • Managing samples accurately throughout the chain • Ethical approval and regulatory compliance Paul Whittaker, Unit Head for Pre-Clinical Biomarkers, Novartis Dr Anne Bahr, R&D Privacy Officer, Sanofi Amir Gander, Senior Knowledge Transfer Associate, University College London 4.40 From bedside to research laboratory: challenges to get appropriate samples and data for biomarker research and development projects • Retrospective, prospective and combined study designs: the need for banked samples and options for prospective collections • About ivory towers: researchers and clinicians should discuss biomarkers studies as early as possible • Don’t expect a one-fits-all solution: the challenge to work within decentralised regulative and ethical environments • Sample/data quality starts even before collection: the need to understand collection logistics at clinical sites • More about quality: SOPs, useful lab tests and monitoring Dr Michael Jürgens, Managing Director, AdeptBio UG 5.20 Chairman’s Closing Remarks and Close of Day Two DIVERSE INSIGHTS INTO BIOBANKING 11.00 11.40 12.20 Research infrastructures in biobanking • The EU policies for research infrastructures • The case of biobanks • The new BBMRI-ERIC • Perspectives under Horizon 2020 Mr Octavi Quintana, Director, Directorate General of Research and Innovation, European Commission The UK ME/CFS Biobank experience • Patient oriented resource building • Infrastructure for data and sample gathering • Open access for academics and industry • Sustainability of a disease specific biobank Dr Luis Nacul, Principal Investigator, Clinical Research Department, London School of Hygiene and Tropical Medicine Networking Lunch BIOBANKING WITHIN THE ERA OF PERSONALISED MEDICINE 1.40 Biobanking and everything around: a case study presentation from European Institute of Oncology (IEO) • The IEO Biobank and Biomolecular Infrastructure (IBBRI) is an institutional infrastructure within the Molecular Medicine Program (MMP) of IEO • Collecting and storing biological specimens from patients through specifically designed informed consent x your registration to +44 (0)870 9090 712 or call +44 (0)870 9090 711 Want to know how you can get involved? Interested in promoting your services to this market? Contact Humaira Kaiser, SMi Marketing on +44 (0) 20 7827 6197, or email: Supported by
  4. 4. POST-CONFERENCE WORKSHOP A Wednesday 25th June 2014 8.30am - 12.15pm Holiday Inn Regents Park Hotel, London, UK Ethics and Research in Biobanking Hosted by Dr Ann Cooreman, COO, Tissue Solutions Overview of workshop: The workshop will give delegates a comprehensive overview of ethics and research with biological samples in the UK. Why you should attend? • You work with biosamples for drug development, diagnostics development, toxicology studies etc. • You would like to find out more about ethics • You want to gain an understanding about the ethical principles underlying governance in the UK and why they are so important • You would like to know about the legal and regulatory requirements in the UK for using human biomaterials in research Programme: 8.30 Registration and Coffee 9.00 Welcome and Introduction 9.15 Definition and discussion of the current Ethics Regulations for Research in Pharma and Biotech in the UK • Who needs Ethics? • HTA and Research • NRES and Research • HTA vs. Research • Ethics Application: what you need to know 10.30 Coffee break 10.45 Research Tissue Banks: what are they? How do they work • Virtual Tissue Banks: what are they, how do they work • Practical exercise: Pros and Cons of virtual Biobanking • Best working practices (national and international) 11.45 Importing Biosamples • Ethics and governance 12.15 General Round Discussion & Close About the workshop host: Dr. Ann Cooreman is a multi career woman. She spent the first 15 years of her working life in academic research and teaching as a linguist. This was followed by a 4 year stint working as Project Manager at IBM. In 2001 she became the Tissue Acquisitionist and Ethics coordinator for a small Biotech company in Glasgow. This eventually led to the founding of Tissue Solutions in 2007 with colleague Dr.Morag MacFarlane. Ann has extensive experience in gaining ethics permission and preparing the associated protocols for prospective collections. Ann has also worked in a business development role and has successfully managed several collaborative tissue based research programs with clients worldwide. About Tissue Solutions: Tissue Solutions is a virtual Biobank, offering a single point of access to an entire range of human biological materials, including diseased and normal human tissues in fresh, frozen and FFPE formats, and body fluids (e.g. blood, serum, plasma, CSF, ascites, urine, sputum, and synovial fluid). Using our large network of sources we find the tissues researchers require for drug discovery and development such as genomics, proteomics, biomarker studies, antibody testing, pharmacology and toxicology studies. For more information about the company:
  5. 5. POST-CONFERENCE WORKSHOP B Wednesday 25th June 2014 1.00pm - 5.30pm Holiday Inn Regents Park Hotel, London, UK Biobanking – start small and grow Hosted by Neil Benn, Managing Director, Ziath Overview of workshop: Biobanking is often thought of as millions of tubes in a highly automated facility which is the image that often hits the headlines. However often a biobank is much more moderate in number; and budget! Therefore this workshop will run through the basic measures needed to setup a biobank taking into account handling samples in an efficient and secure manner and also detailing the potential paths of upgrading as the number of samples and complexity of the processing of these samples grows. Why you should attend • Looking to set up a new Biobank • Looking to manage samples on a budget • Curious about new technologies • Looking to make efficiencies in your existing biobank Programme: 1.00 Registration and coffee 1.30 Introduction and outline 2.00 What is a biobank? 2.30 Coffee break 2.45 Storage issues 3.00 Informatics issues in biobanking including practical demonstrations 3.30 Sample and data security 4.00 Scaling your biobank up - Things to consider 4.30 Biobank case studies 5.00 Q&A session 5.30 Close of workshop About the workshop host: Neil Benn is the Managing Director of Ziath Ltd, a company dedicated to sample management; previous to this Neil held roles in academia and industry in organisations such as the Max Planck society and GSK. Neil holds a bachelors in Biotechnology and a Masters in Computer Science. About Ziath: Ziath Ltd is a company dedicated to sample management; founded and run by scientists and engineers they design and provide the tools, expertise and advice needed to manage your samples in a cost-effective manner.
  6. 6. BIOBANKING Conference: Monday 23rd & Tuesday 24th June 2014, Holiday Inn Regents Park Hotel, London, UK Workshops: Wednesday 25th June 2014, London 4 WAYS TO REGISTER FAX your booking form to +44 (0) 870 9090 712 PHONE on +44 (0) 870 9090 711 POST your booking form to: Events Team, SMi Group Ltd, 2nd Floor South, Harling House, 47-51 Great Suffolk Street, London, SE1 0BS, UK EARLY BIRD □ DISCOUNT □ Book by 28th February to receive £300 off the conference price Book by 31st March to receive £100 off the conference price CONFERENCE PRICES Unique Reference Number Our Reference LV P-108 DELEGATE DETAILS Please complete fully and clearly in capital letters. Please photocopy for additional delegates. Title: Forename: Surname: I would like to attend: (Please tick as appropriate) □ Conference & 2 Workshops □ Conference & 1 Workshop □ Conference only □ 1 Workshop only □ 2 Workshops AM Workshop □ PM Workshop □ Fee £2697.00 £2098.00 £1499.00 £599.00 £1198.00 PROMOTIONAL LITERATURE DISTRIBUTION □ Distribution of your company’s promotional literature to all conference attendees £999.00 Job Title: Department/Division: Company/Organisation: + VAT + VAT + VAT + VAT + VAT Total £3236.40 £2517.60 £1798.80 £718.80 £1437.60 + VAT £1198.80 The conference fee includes refreshments, lunch, conference papers and access to the Document Portal containing all of the presentations. Email: Company VAT Number: Address: LIVE STREAMING/ON DEMAND/ DOCUMENTATION Unable to travel, but would like to watch the conference live, ask questions, participate as if you were in the room? Price Total Town/City: Post/Zip Code: Country: Direct Tel: Direct Fax: □ Live Streaming □ On demand Mobile: (available 24 hours after the event) □ Access to the conference documentation Switchboard: Signature: Date: I agree to be bound by SMi's Terms and Conditions of Booking. ACCOUNTS DEPT Title: £999.00 + VAT (UK) £1198.80 £599.00 + VAT (UK) £718.80 on the Document Portal £499.00 + VAT £499.00 (or only £300 if ordered with the Document Portal) □ The Conference Presentations - paper copy £598.80 £499.00 Forename: Surname: PAYMENT Email: Payment must be made to SMi Group Ltd, and received before the event, by one of the following methods quoting reference P-108 and the delegate’s name. Bookings made within 7 days of the event require payment on booking, methods of payment are below. Please indicate method of payment: Address (if different from above): Town/City: Post/Zip Code: Country: Direct Tel: □ UK BACS □ Wire Transfer Direct Fax: VENUE Holiday Inn, Regents Park, Carburton Street, London, W1W 5EE □ Please contact me to book my hotel Alternatively call us on +44 (0) 870 9090 711, email: or fax +44 (0) 870 9090 712 Terms and Conditions of Booking Payment: If payment is not made at the time of booking, then an invoice will be issued and must be paid immediately and prior to the start of the event. If payment has not been received then credit card details will be requested and payment taken before entry to the event. Bookings within 7 days of event require payment on booking. Access to the Document Portal will not be given until payment has been received. Substitutions/Name Changes: If you are unable to attend you may nominate, in writing, another delegate to take your place at any time prior to the start of the event. Two or more delegates may not ‘share’ a place at an event. Please make separate bookings for each delegate. Cancellation: If you wish to cancel your attendance at an event and you are unable to send a substitute, then we will refund/credit 50% of the due fee less a £50 administration charge, providing that cancellation is made in writing and received at least 28 days prior to the start of the event. Regretfully cancellation after this time cannot be accepted. We will however provide the conferences documentation via the Document Portal to any delegate who has paid but is unable to attend for any reason. Due to the interactive nature of the Briefings we are not normally able to provide documentation in these circumstances. We cannot accept cancellations of orders placed for Documentation or the Document Portal as these are reproduced specifically to order. If we have to cancel the event for any reason, then we will make a full refund immediately, but disclaim any further liability. Alterations: It may become necessary for us to make alterations to the content, speakers, timing, venue or date of the event compared to the advertised programme. Data Protection: The SMi Group gathers personal data in accordance with the UK Data Protection Act 1998 and we may use this to contact you by telephone, fax, post or email to tell you about other products and services. Unless you tick here □ we may also share your data with third parties offering complementary products or services. If you have any queries or want to update any of the data that we hold then please contact our Database Manager or visit our website quoting the URN as detailed above your address on the attached letter. □ Cheque □ Credit Card Sort Code 300009, Account 00936418 Lloyds TSB Bank plc, 39 Threadneedle Street, London, EC2R 8AU Swift (BIC): LOYDGB21013, Account 00936418 IBAN GB48 LOYD 3000 0900 9364 18 We can only accept Sterling cheques drawn on a UK bank. □ Visa □ MasterCard □ American Express All credit card payments will be subject to standard credit card charges. □□□□ □□□□ □□□□ □□□□ Valid From □□/□□ Expiry Date □□/□□ CVV Number □□□□ 3 digit security on reverse of card, 4 digits for AMEX card Card No: Cardholder’s Name: Signature: Date: I agree to be bound by SMi's Terms and Conditions of Booking. Card Billing Address (If different from above): VAT VAT at 20% is charged on the attendance fees for all delegates. VAT is also charged on live Streaming, on Demand, Document portal and literature distribution for all UK customers and for those EU Customers not supplying a registration number for their own country here. ______________________________________________________________________________________________ If you have any further queries please call the Events Team on tel +44 (0) 870 9090 711 or you can email them at